Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-αvβ3 interactions

Blood

Volumn 104, Issue 12, 2004, Pages 3774-3781

  Zennadi, Rahima ^b   Hines, Patrick C ^b   De Castro, Laura M ^b   Cartron, Jean Pierre ^b   Parise, Leslie V ^b   Telen, Marilyn J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIGEN; CD242 ANTIGEN; CELL ADHESION MOLECULE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 4; PHOSPHATASE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CELL ADHESION; CELL IMMORTALIZATION; CELL INTERACTION; CELL MATURATION; CLINICAL PATHWAY; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SICKLE CELL; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; STRESS; UMBILICAL VEIN;

EID: 4544273781     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0042     Document Type: Article

References (41)

1. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: a possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest. 1980;65:154-160.
2. Mohandas N, Evans E. Sickle erythrocyte adherence to the vascular endothelium: morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins. J Clin Invest. 1985;76:1605-1612.
3. Kaul DK, Fabry ME, Nagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci USA. 1989;86:3356-3360.
4. Minetti G, Low PS. Erythrocyte signal transduction pathways and their possible functions. Curr Opinion Hematol. 1997;4:116-121.
5. Brittain JE, Mlinar KJ, Anderson CS, Orringer EP, Parise LV. Activation of sickle red blood cell adhesion via integrin associated protein/CD47-induced signal transduction. J Clin Invest. 2001;107:1555-1562.
6. Brittain JE, Anderson CS, Orringer EP, Parise LV. Integrin-associated protein (IAP/CD47) stimulate sickle (SS) RBC adhesion to vitronectin by inducing phosphatidylserine exposure; novel roles for calpain and the cytoskeleton in the SS RBC [abstract]. Blood. 2001;98:483a.
7. Mines PC, Zen Q, Burney SN, et al. Novel epinephrine and cyclic AMP activation of B-CAM/Lu-dependent sickle (SS) RBC adhesion. Blood. 2003;101:3281-3287.
8. Kaul DK, Tsai HM, Liu XD, Nakada MT, Nagel RL, Coller BS. Monoclonal antibodies to alphavbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood. 2000;95:368-374.
9. Fontijn R, Hop C, Brinkman HJ, et al. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Experim Cell Res. 1995;216:199-207.
10. Vordermeier S, Singh S, Biggerstaff J, et al. Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumour necrosis factor (TNF). Brit J Haematol. 1992;81:591-597.
11. Sultana C, Shen Y, Johnson C, Kalra VK. Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist. J Cell Physiol. 1999;179:67-78.
12. Haynes BF, Hemler M, Cotner T, et al. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol. 1981;127:347-351.
13. Bloy C, Blanchard D, Hermand P, Kordowicz M, Sonneborn HH, Cartron JP. Properties of the blood group LW glycoprotein and preliminary comparison with Rh proteins. Mol Immunol. 1989; 26:1013-1019.
14. Lindberg FP, Lublin DM, Telen MJ, et al. Rh-related antigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem. 1994;269: 1567-1570.
15. Telen MJ, Eisenbarth GS, Haynes BF. Human erythrocyte antigens: regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest. 1983;71: 1878-1886.
16. Galfre G, Howe SC, Milstein C, Butcher GW, Howard JC. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature. 1977;266:550-552.
17. Xiao Y, Truskey GA. Effect of receptor-ligand affinity on the strength of adhesion of endothelial cells. Biophys J. 1996;71:2869-2884.
18. Udani M, Zen Q, Cottman M, et al. Basal cell adhesion molecule/Lutheran protein: the receptor critical for sickle cell adhesion to laminin. J Clin Invest. 1998;11:2550-2558.
19. Cheung AT, Harmatz P, Wun T, et al. Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001;97:3401-3404.
20. Hermand P, Huet M, Callebaut I, et al. Binding sites of leukocyte beta 2 integrins (LFA-1, Mac-1) on the human ICAM-4/LW blood group protein. J Biol Chem. 2000;275:26002-26010.
21. Haynes BF, Hale LP, Patton KL, Martin ME, McCallum RM. Measurement of an adhesion molecule as an indicator of inflammatory disease activity: up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arth Rheum. 1991;34:1434-1443.
22. Brunati AM, Bordin L, Clari G, et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood. 2000;96:1550-1557.
23. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
24. Spring FA, Parsons SF, Ortlepp S, et al. Intercellular adhesion molecule-4 binds α4β1 and αv-family integrins through novel integrin-binding mechanisms. Blood. 2001;98:458-466.
25. Hermand P, Hue M, Callebaut I, et al. Binding sites of leukocyte β2 integrins (LFA-1, Mac-1) on the human ICAM-4/LW blood group protein. J Biol Chem. 2000;275:26002-26010.
26. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia: a possible determinant of disease severity. N Engl J Med. 1980;302:992-995.
27. Sager G. Receptor binding sites for beta-adrenergic ligands on human erythrocytes. Biochem Pharmacol. 1982;31:99-104.
28. Sager G, Jacobsen S. Effect of plasma on human erythrocyte beta-adrenergic receptors. Biochem Pharmacol. 1985;34:3767-3771.
29. 2+ influx and cAMP-mediated signaling pathways. Amer J Physiol. 1997;273:C1828-C1834.
30. Krishnan R, Brown KA, Pearson TC. Increased expression of Lutheran and LW glycoproteins on red blood cells from patients with sickle cell disease [abstract]. Brit J Haematol. 1999;105:64(suppl 1).
31. Jindal HK, Ai Z, Gascard P, Horton C, Cohen CM. Specific loss of protein kinase activities in senescent erythrocytes. Blood. 1996;88:1479-1487.
32. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1997;390:88-91.
33. Garland EM, Biaggioni I. Genetic polymorphisms of adrenergic receptors. Clin Auton Res. 2001;11:67-78.
34. Buscher R, Hermann V, Insel PA. Human adrenoceptor polymorphisms: evolving recognition of clinical importance. Trends Pharmacol Sci. 1999;20:94-99.
35. Brown KA, Mahmalji R, Pearson TC. Antibody blocking of sickled red blood cell attachment to cultured endothelium [abstract]. Brit J Haematol. 1998;102:279.
36. Brown KA, Mahmalji R, Pearson TC. The contribution of CD47 and LW glycoprotein (ICAM-4) to the binding of sickled erythrocytes to cultured endothelium [abstract]. Brit J Haematol. 1998; 101:25(suppl 1).
37. Hermand P, Gane P, Huet M, et al. Red cell ICAM-4 is a novel ligand for platelet activated α11bβ3-integrin. J Biol Chem. 2003;278:4892-4898.
38. Porzig H, Gutknecht R, Kostova G, Thalmeier K. G-protein-coupled receptors in normal human erythroid progenitor cells. Naunyn-Schmiedeberg's Arch Pharmacol. 1995;353:11-20.
39. Baumann R, Blass C, Gotz R, Dragon S. Ontogeny of catecholamine and adenosine receptor-mediated cAMP signaling of embryonic red blood cells: role of cGMP-inhibited phosphodiesterase 3 and hemoglobin. Blood. 1999;94:4314-4320.
40. Lafrenie RM, Podor TJ, Buchanan MR, Orr FW. Up-regulated biosynthesis and expression of endothelial cell vitronectin receptors enhances cancer cell adhesion. Cancer Res. 1982;52:2202-2208.
41. Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, Tarone G. Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin β3) in human endothelial cells. J Biol Chem. 1991;266:7638-7645.